Clinical Trial

NK510 Cell Therapy for Refractory Systemic Lupus Erythematosus

Name: NK510 Cell Therapy for Refractory Systemic Lupus Erythematosus — clinical trial record (NCT07083349)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting

View on ClinicalTrials.gov →

Summary

This is an investigator-initiated, open-label, single-arm study to determine safety and preliminary efficacy of NK510 for the treatment of patients with refractory systemic lupus erythematosus (SLE) in China.

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2025-07-16.

Trial Details

NCT Number	NCT07083349
Lead Sponsor	Base Therapeutics (Shanghai) Co., Ltd. Collaborators: The First Affiliated Hospital of Anhui Medical University
Conditions	Refractory Systemic Lupus Erythematosus
Enrollment	9 participants
Start Date	2025-08-01
Primary Completion	2027-09-01 (estimated)
Study Completion	2027-09-01 (estimated)
Updated on ClinicalTrials.gov	2025-07-28